Cryptocurrency & Digital Assets

The biotech firm's oversubscribed funding round will accelerate its universal flu shot and a diverse pipeline targeting cancer, malaria, and Alzheimer's.

Birchtech launches its SEA-IX™ resin line, aiming to disrupt a consolidated market and bolster supply chains for critical nuclear and water utilities.

Danish firm Evaxion, backed by the Gates Foundation, uses its AI platform to design a next-gen polio vaccine, aiming to end the disease for good.

HistoSonics begins a landmark trial for a non-invasive BPH therapy that uses focused ultrasound to mechanically destroy tissue without incisions or heat.

A new partnership between Takara Bio and Hamilton promises to revolutionize RNA-seq, making high-throughput genomic analysis faster and more reliable.

Tenpoint Therapeutics launches YUVEZZI, a once-daily drop for presbyopia, entering a fierce market with a novel two-in-one formula for aging eyes.

An amended deal with Tasly positions AP Biosciences to license its innovative bispecific cancer therapy to global pharma giants, targeting a lucrative market.

Dubai's AIR, owner of Al Fakher, is going public via a SPAC merger. Can it navigate a tricky market and health debates to find growth on Wall Street?

South Korean AI chip leader Rebellions raises $400M, launching full-stack AI systems to redefine efficient inference and spearhead a global expansion.

Backed by a Turkish mining giant, Capella Minerals starts crucial soil sampling in Finland's prolific gold belt, seeking the next major discovery.

Chef Gabriela Cámara and architect Frida Escobedo debut a sanctuary of Mexican hospitality, offering a quiet, authentic counterpoint to the Vegas spectacle.

As Precigen leaders prepare for a key investor chat, all eyes are on the explosive launch of PAPZIMEOS and the company's ambitious path to profitability.

With a new president and a recent acquisition, Once Upon a Coconut is scaling rapidly, leveraging deep industry experience to challenge beverage giants.

Avory & Co. enters the crowded ETF market with AVRY, an actively managed fund shunning trends for a concentrated portfolio of high-quality stocks.

An ETF offers retail investors a ticket to SpaceX's massive IPO, but a bitter public dispute with critics raises questions about transparency and risk.

The Mediterranean chain is betting on the "swicy" trend, launching a Hot Honey Harissa menu and new fries to challenge fast-casual rivals.

PMGC Holdings touts major acquisitions and a promising biotech pipeline, but a look at its financials reveals a high-stakes bet on future growth.

Magnachip's new power semiconductors promise major efficiency and density gains for servers, tackling the soaring energy needs of the growing AI boom.

Canadian explorer BluEnergies begins trading on OTCQX, aiming to leverage U.S. capital for its ambitious oil projects in West Africa and the Gulf of Mexico.

Franklin BSP Realty Trust's major debt deal shows strong investor faith in its multifamily strategy, a bright spot in a cautious real estate market.